cbdMD Poised for Growth After White House Urges Extended Hemp Regulation Timeline
YCBD•The White House Office of Management and Budget urged Congress to preserve access to full-spectrum CBD products and extend the hemp regulation timeline to ensure safety standards. cbdMD, an NYSE American–listed wellness company with national distribution and hemp-derived brands, says it is well-positioned for regulatory clarity and market maturity.
1. White House Urges Hemp Regulation Reform
The White House Office of Management and Budget urged Congress to preserve access to full-spectrum CBD products and extend the hemp regulation timeline, seeking new federal standards to ensure product safety and consumer protection.
2. cbdMD Highlights Strategic Market Positioning
cbdMD’s leadership celebrated the call for clear, science-backed hemp rules, citing its status as an NYSE American–listed wellness company with national distribution and established hemp-derived brands as key competitive advantages in a regulated market.
3. Exchange Listings Reflect Category Maturity
Recent approval of cannabis operator listings on major U.S. exchanges underscores growing legitimacy and investor interest in the cannabinoid category, trends that cbdMD expects to leverage as regulatory clarity and market maturity advance.
